| Code | CSB-RA911751A0HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:5000 |
| FC | 1:50-1:200 |
Metadherin, also known as astrocyte elevated gene-1 protein or LYRIC, has emerged as a significant focus in cancer biology research due to its multifaceted roles in tumor progression, metastasis, and therapeutic resistance. This protein functions as a key mediator in several oncogenic signaling pathways, including NF-κB, PI3K/AKT, and Wnt/β-catenin, making it a valuable target for researchers investigating signal transduction mechanisms underlying malignant transformation and cancer cell survival.
This recombinant monoclonal antibody, clone 24E5, offers the reproducibility and consistency that demanding experimental workflows require. Generated through recombinant technology in rabbit host, this antibody provides sequence-defined specificity against human MTDH, ensuring reliable performance across experiments and eliminating the lot-to-lot variability that can complicate long-term studies.
Validation testing demonstrates robust performance across multiple applications. In western blot analysis, the antibody successfully detects MTDH in diverse human cancer cell lines including U-251MG glioblastoma, PC-3 prostate cancer, MCF-7 breast cancer, and HepG2 hepatocellular carcinoma cells. The observed band at approximately 75 kDa, compared to the predicted molecular weight of 64 kDa, likely reflects post-translational modifications such as glycosylation that are characteristic of this protein in cellular contexts. Flow cytometry validation using K562 cells confirms the antibody's utility for intracellular detection applications, with clear signal separation from isotype controls.
The antibody's compatibility with ELISA, western blot, and flow cytometry provides researchers with flexibility across experimental platforms. For investigators studying metastasis mechanisms, therapeutic resistance pathways, or oncogenic signaling networks, this antibody delivers the specificity and validated performance needed to advance understanding of MTDH biology in human cancer models.
There are currently no reviews for this product.